DoD Breast Cancer, Clinical Research Extension Award

The Department of Defense (DOD) has issued a program announcement for the FY25 Breast Cancer Research Program (BCRP) Clinical Research Extension Award, with a funding opportunity number HT942525BCRPCREA2. The initiative aims to enhance clinical research focused on breast cancer through improved data collection, patient follow-up, and analysis, addressing loss of knowledge due to incomplete studies. Applications are invited from various organizations and must include consumer advocates with breast cancer experience. Funding is approximately $8.4 million, with a cap of $7 million for single Principal Investigators (PIs) and $8.4 million for those using a Partnering PI Option. The application process is two-step, requiring a pre-application by August 27, 2025, followed by a full application due September 10, 2025. The review process emphasizes the research's impact, feasibility, and the expertise of the research team, particularly the involvement of consumer advocates. Successful applicants will receive awards no later than September 30, 2026, funded with FY25 appropriations expiring in September 2031. This program aligns with the DOD's mission to combat breast cancer and seeks to stimulate innovative research that has significant clinical relevance.